1-Piperidinecarboxylic acid, 4-[[5-methyl-3-(1-methylethyl)pyrazolo[1,5-a]pyrimidin-7-yl]amino]-, 1-[(2E)-4-(dimethylamino)-1-oxo-2-buten-1-yl]-3-pyrrolidinyl ester

1-Piperidinecarboxylic acid, 4-[[5-methyl-3-(1-methylethyl)pyrazolo[1,5-a]pyrimidin-7-yl]amino]-, 1-[(2E)-4-(dimethylamino)-1-oxo-2-buten-1-yl]-3-pyrrolidinyl ester Struktur
2326428-25-3
CAS-Nr.
2326428-25-3
Englisch Name:
1-Piperidinecarboxylic acid, 4-[[5-methyl-3-(1-methylethyl)pyrazolo[1,5-a]pyrimidin-7-yl]amino]-, 1-[(2E)-4-(dimethylamino)-1-oxo-2-buten-1-yl]-3-pyrrolidinyl ester
Synonyma:
anticancer,Cyclin dependent kinase,CDK,MCF7,SNU-16,Cyclin-dependent kinase,LY 3405105,LY3405105,HCC1806,inhibit,Inhibitor,LY-3405105,HCT116;(3S)-1-[(E)-4-(dimethylamino)but-2-enoyl]pyrrolidin-3-yl] 4-[(3-isopropyl-5-methylpyrazolo[1,5-a]pyrimidin-7-yl)amino]piperidine-1-carboxylate;1-Piperidinecarboxylic acid, 4-[[5-methyl-3-(1-methylethyl)pyrazolo[1,5-a]pyrimidin-7-yl]amino]-, 1-[(2E)-4-(dimethylamino)-1-oxo-2-buten-1-yl]-3-pyrrolidinyl ester
CBNumber:
CB38241093
Summenformel:
C26H39N7O3
Molgewicht:
497.63
MOL-Datei:
2326428-25-3.mol

1-Piperidinecarboxylic acid, 4-[[5-methyl-3-(1-methylethyl)pyrazolo[1,5-a]pyrimidin-7-yl]amino]-, 1-[(2E)-4-(dimethylamino)-1-oxo-2-buten-1-yl]-3-pyrrolidinyl ester Eigenschaften

Dichte
1.27±0.1 g/cm3(Predicted)
storage temp. 
Store at -20°C
Löslichkeit
DMSO: 99 mg/mL (198.94 mM);Ethanol: 99 mg/mL (198.94 mM)
pka
8.26±0.28(Predicted)
Wasserlöslichkeit
Water: Insoluble

Sicherheit

1-Piperidinecarboxylic acid, 4-[[5-methyl-3-(1-methylethyl)pyrazolo[1,5-a]pyrimidin-7-yl]amino]-, 1-[(2E)-4-(dimethylamino)-1-oxo-2-buten-1-yl]-3-pyrrolidinyl ester Chemische Eigenschaften,Einsatz,Produktion Methoden

1-Piperidinecarboxylic acid, 4-[[5-methyl-3-(1-methylethyl)pyrazolo[1,5-a]pyrimidin-7-yl]amino]-, 1-[(2E)-4-(dimethylamino)-1-oxo-2-buten-1-yl]-3-pyrrolidinyl ester Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte


1-Piperidinecarboxylic acid, 4-[[5-methyl-3-(1-methylethyl)pyrazolo[1,5-a]pyrimidin-7-yl]amino]-, 1-[(2E)-4-(dimethylamino)-1-oxo-2-buten-1-yl]-3-pyrrolidinyl ester Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 9)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
TargetMol Chemicals Inc.
+1-781-999-5354
support@targetmol.com United States 19973 58
Aladdin Scientific
+1-+1(833)-552-7181
sales@aladdinsci.com United States 57511 58
ShangHai Caerulum Pharma Discovery Co., Ltd. 18149758185
sales-cpd@caerulumpharma.com China 3429 58
ShangHai Biochempartner Co.,Ltd 17754423994 17754423994
2853530910@QQ.com China 8019 62
Dezhou LonWel Pharmaceutical Technology Co., Ltd. 13761310616
39324283@qq.com China 1985 58
DC Chemicals 021-58447131 13564518121
sales@dcchemicals.com China 9412 58
TargetMol Chemicals Inc. 4008200310
marketing@tsbiochem.com China 24017 58
Shanghai Aladdin Biochemical Technology Co.,Ltd. +86-18521732826
market@aladdin-e.com China 48467 58
Nanjing Shizhou Biology Technology Co.,Ltd 025-85560043 15850508050
cindy.huang@synzest.com China 12007 58

  • (3S)-1-[(E)-4-(dimethylamino)but-2-enoyl]pyrrolidin-3-yl] 4-[(3-isopropyl-5-methylpyrazolo[1,5-a]pyrimidin-7-yl)amino]piperidine-1-carboxylate
  • 1-Piperidinecarboxylic acid, 4-[[5-methyl-3-(1-methylethyl)pyrazolo[1,5-a]pyrimidin-7-yl]amino]-, 1-[(2E)-4-(dimethylamino)-1-oxo-2-buten-1-yl]-3-pyrrolidinyl ester
  • anticancer,Cyclin dependent kinase,CDK,MCF7,SNU-16,Cyclin-dependent kinase,LY 3405105,LY3405105,HCC1806,inhibit,Inhibitor,LY-3405105,HCT116
  • 2326428-25-3
Copyright 2019 © ChemicalBook. All rights reserved